RankingsPricing
  1. JP-listed companies
  2. JCR Pharmaceuticals Co.,Ltd.
  3. Financials
  4. Stockholders' equity

JCR Pharmaceuticals Co.,Ltd.【JP:4552】

Market cap
¥91.7B
P/E ratio
29.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 202547,435-16.01%
Mar 31, 202456,475+7.75%
Mar 31, 202352,413+2.59%
Mar 31, 202251,089+32.50%
Mar 31, 202138,557+18.35%
Mar 31, 202032,579+5.52%
Mar 31, 201930,874+12.15%
Mar 31, 201827,528-0.21%
Mar 31, 201727,586+1.93%
Mar 31, 201627,063+3.04%
Mar 31, 201526,265+6.85%
Mar 31, 201424,581

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)